Filter News
Area of Research
News Topics
- (-) Mercury (3)
- (-) Summit (4)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (1)
- Artificial Intelligence (4)
- Big Data (1)
- Bioenergy (9)
- Biology (14)
- Biomedical (6)
- Biotechnology (3)
- Buildings (2)
- Chemical Sciences (2)
- Clean Water (3)
- Climate Change (3)
- Computer Science (14)
- Coronavirus (2)
- Cybersecurity (1)
- Decarbonization (3)
- Energy Storage (5)
- Environment (21)
- Exascale Computing (2)
- Frontier (1)
- Fusion (1)
- Grid (1)
- High-Performance Computing (9)
- Isotopes (6)
- ITER (1)
- Materials (4)
- Materials Science (6)
- Microscopy (3)
- Nanotechnology (3)
- National Security (4)
- Neutron Science (6)
- Nuclear Energy (4)
- Physics (2)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (4)
- Security (2)
- Space Exploration (1)
- Sustainable Energy (7)
- Transportation (6)
Media Contacts
Energy Secretary Jennifer Granholm visited ORNL on Nov. 22 for a two-hour tour, meeting top scientists and engineers as they highlighted projects and world-leading capabilities that address some of the country’s most complex research and technical challenges.
A team led by ORNL and the University of Michigan have discovered that certain bacteria can steal an essential compound from other microbes to break down methane and toxic methylmercury in the environment.
Anyone familiar with ORNL knows it’s a hub for world-class science. The nearly 33,000-acre space surrounding the lab is less known, but also unique.
Moving to landlocked Tennessee isn’t an obvious choice for most scientists with new doctorate degrees in coastal oceanography.
Improved data, models and analyses from ORNL scientists and many other researchers in the latest global climate assessment report provide new levels of certainty about what the future holds for the planet
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Since the 1930s, scientists have been using particle accelerators to gain insights into the structure of matter and the laws of physics that govern our world.